Median (IQR) | P-value of between-subjects effect | |||
---|---|---|---|---|
Injection latency | Seizure duration | Interaction | ||
Age at ictal SPECT, y | 38 (26–49) | 0.052 | 0.403 | 0.997 |
Sex, % females | 47.2 | 0.327 | 0.481 | 0.949 |
Age at first seizure, y | 15 (7–24) (n = 64) | 0.240 | 0.708 | 0.427 |
Duration of disease at SPECT, y | 20 (10–31) (n = 65) | 0.615 | 0.151 | 0.866 |
Mean seizure frequency in the last 12 mo before SPECT, seizures/mo | 9 (5–22) (n = 50) | 0.650 | 0.783 | 0.770 |
Tracer of ictal SPECT, % 99mTc-ECD | 20.5 | 0.978 | 0.051 | 0.445 |
Injected tracer dose, MBq | 590 (505–700) (n = 115) | 0.529 | 0.561 | 0.618 |
Delay between tracer injection and scan start, min | 141 (100–188) (n = 93) | 0.752 | 0.834 | 0.735 |